BioCatalyst

Dazodalibep — catalyst calendar

2 verified catalyst event(s) referencing Dazodalibep, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-19
in 2mo
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With
Phase 3 · Sjogren's Syndrome
 AMGN AMGEN INC Dazodalibep ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10-22
in 4mo
ESTIMATED
 READOUT
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndro
Phase 3 · Sjögren's Syndrome (SS)
 AMGN AMGEN INC Dazodalibep ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.